11:12 AM EDT, 09/03/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were falling late Tuesday morning, declining 1.60% to 1,457.09 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Sanofi ( SNY ) and semiconductor company Sequans Communications ( SQNS ) , which rose 2.6% and 2%, respectively. They were followed by telecommunications operator Telefonica ( TEF ) , which increased 1.9%.

The decliners from continental Europe were led by biopharmaceutical companies Cellectis ( CLLS ) and Genfit ( GNFT ) , which fell 5.8% and 5.5%, respectively. They were followed by petroleum refiner Equinor ( EQNR ) , which 4.7%.

From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Akari Therapeutics ( AKTX ) , which advanced 12% and 4.6% respectively. They were followed by biopharmaceutical company NuCana ( NCNA ) and pharmaceutical firm Silence Therapeutics ( SLN ) , which were up 4.4% and 3.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and biotech firm Trinity Biotech ( TRIB ) , which lost 16% and 6.5% respectively. They were followed by mining company BHP Group ( BHP ) and software firm Endava ( DAVA ) , which were down 5.5% and 4.9% respectively.